Gapping down
In reaction to disappointing earnings/guidance: XNET -14%, NTAP -12.6%, (Also - disclosed it committed to a realignment designed to drive efficiency, eliminate cost and redirect resources; expects to reduce headcount by ~500 employees RXN -11.5%, BRS -5.9%, SMRT -5.8%, SCVL -4.9%, DLTR -4.3%, AAP -4.1%, SNPS -3.5%, BONT -3.2%, MNRO -2.8%, BKE -2.6%,OTEX -2.4%, ( announces Mark Barrenechea, President and CEO resumed full involvement in day-to-day operations; sees Q4 EPS and revs below consensus)
Other news: LL -17.4% (CEO resigns), BRKR -10% (CFO Charles Wagner has submitted his resignation), FATE -8% (prices 6,000,000 shares of its common stock at $5.00 per share), OXGN -5.8% (filed for $75 mln mixed securities shelf offering), DRNA -5.3% (prices 2,750,000 shares of its common stock at $17.75 per share), AETI -5.2% filed for $25 mln offering of common stock, warrants, and units), AGEN -4.2% (intends to offer shares of its common stock in an underwritten public offering ), OCUL -2% (filed for $125 mln common stock offering by selling shareholders), SABR -1.8% (prices 24,000,000 shares of common stock by existing stockholders at a price of $26.00 per share), ARCI -1.7% (announced the return of Edward Cameron as President and CEO), SYT -1.2% (cont vol surrounding M&A spec), TRUE -1.1% (following late move lower on reports of California Dealers lawsuit), ARMK -1% (announces a 25 mln share secondary offering of common stock by selling stockholders)
Analyst comments: WBAI -5.6% (downgraded to Sell at Deutsche Bank ), SRPT -3.7% (downgraded to Neutral from Buy at BofA/Merrill), SFUN -1.8% (downgraded to Hold at Brean Capital), DDD -0.9% (downgraded to Perform from Outperform at Oppenheimer)
In reaction to disappointing earnings/guidance: XNET -14%, NTAP -12.6%, (Also - disclosed it committed to a realignment designed to drive efficiency, eliminate cost and redirect resources; expects to reduce headcount by ~500 employees RXN -11.5%, BRS -5.9%, SMRT -5.8%, SCVL -4.9%, DLTR -4.3%, AAP -4.1%, SNPS -3.5%, BONT -3.2%, MNRO -2.8%, BKE -2.6%,OTEX -2.4%, ( announces Mark Barrenechea, President and CEO resumed full involvement in day-to-day operations; sees Q4 EPS and revs below consensus)
Other news: LL -17.4% (CEO resigns), BRKR -10% (CFO Charles Wagner has submitted his resignation), FATE -8% (prices 6,000,000 shares of its common stock at $5.00 per share), OXGN -5.8% (filed for $75 mln mixed securities shelf offering), DRNA -5.3% (prices 2,750,000 shares of its common stock at $17.75 per share), AETI -5.2% filed for $25 mln offering of common stock, warrants, and units), AGEN -4.2% (intends to offer shares of its common stock in an underwritten public offering ), OCUL -2% (filed for $125 mln common stock offering by selling shareholders), SABR -1.8% (prices 24,000,000 shares of common stock by existing stockholders at a price of $26.00 per share), ARCI -1.7% (announced the return of Edward Cameron as President and CEO), SYT -1.2% (cont vol surrounding M&A spec), TRUE -1.1% (following late move lower on reports of California Dealers lawsuit), ARMK -1% (announces a 25 mln share secondary offering of common stock by selling stockholders)
Analyst comments: WBAI -5.6% (downgraded to Sell at Deutsche Bank ), SRPT -3.7% (downgraded to Neutral from Buy at BofA/Merrill), SFUN -1.8% (downgraded to Hold at Brean Capital), DDD -0.9% (downgraded to Perform from Outperform at Oppenheimer)